Newsletter Subject

Small-Cap Watch: Ready to Pop? 🍾

From

marketnavigatortrading.com

Email Address

JeffWilliams@b.marketnavigatortrading.com

Sent On

Mon, May 20, 2024 01:07 PM

Email Preheader Text

This is ready to go…

This is ready to go…                                                                                                                                                                                                                                                                                                                                                                                                                 May 20, 2024 | [Read Online]( Small-Cap Watch: Ready to Pop? 🍾 This is ready to go… Morning Folks! Jeff Bishop here again with another hot stock idea. As you start your week off, make sure you check out the [Market Masters live trading room](. This is where you’ll find updates on stocks I talk about and also new ideas the community is trading. We used to price this at over $100/month… but I’m giving it away to everyone at absolutely no cost right now. [Take advantage of this great opportunity]( for more education and trading ideas each week. Now, as I discussed in last night’s email, the small-cap market has been roaring back to life in no small part due to “Roaring Kitty” and his legion of rabid following of traders on Reddit and X. It’s a good window of time to look for strong momentum stocks that could keep moving higher (like the recent biotech stock I shared with you that rallied over 30%, or the “Bird Flu” stock that went up over 50% after I shared them both with you.) I also think there is a great opportunity when it comes to searching for “bottom bounce” opportunities. You know, those stocks that have gotten to a point where they are so oversold, that it is almost a no-brainer they will bounce back at some point. That is exactly what I have in store for you today. Go to your platform and pull up MIRA Pharmaceuticals (MIRA) right now. It’s almost too irresistible right now. MIRA has been completely ignored by traders for so long, and I think now is the perfect time to get it back on your radar. You’ll notice that the stock price has slowly drifted all the way down to around $.60 today, but it has traded over 10 times higher than that earlier in the year. If you look back to the chart in March, you’ll see just how fast this stock can run when it wants to. That is when MIRA made a 2-day power surge that carried the shares over 100% higher at one point. If you go back a few more months, you'll see the move we all dream about… that is when MIRA shot up over 370% over the course of a few days. I doubt we’ll see a move like that anytime soon, but one can certainly dream! When it comes to the current price levels, this is where it gets really interesting for me. Since MIRA tested $.63 a few times, I would personally set a closing price just under that as a stop, or the point I would go to the sidelines.  It’s only around $.05 lower than the current price, so there is not much downside if that is properly managed. On the upside though, just look at how much range there is? The last resistance point when MIRA bounced last month was $.90, or over 40% higher from here. I am not saying the stock will suddenly shoot there, but it gives you a good perspective on the upside vs downside ranges to look for. With so many traders out there searching for new opportunities in the small-cap space, I think it makes perfect sense MIRA could be a rebound target. Just last week, Zacks [issued a report]( that said MIRA has a “Potential Game-Changing Drug Submission.” Exposure like that could be just the thing that creates enough spark to get investors fired up about this stock once again. Make sure you are closely watching MIRA today! Let’s discuss more about what MIRA is working on right now. As you know, anxiety impacts a lot of people, making it a big market for drug companies. And sadly it’s growing fast (bad for people) but great for companies. How big is it, and how fast is it growing? Source: [RESEARCH AND MARKETS]( But there’s hope. From marijanua (arguably) to psychedelic mushrooms (Steve Jobs was right again) to new therapeutics - solutions are coming to market at a seemingly record pace. This brings me to MIRA, a tiny biotech that is targeting a potential $3 billion market by 2035, with estimates rising to $7.8 billion, [according to IQVIA](. Yet it’s trading with a market cap of just under $10 million as of Friday’s closing price (reported by Yahoo Finance). And with its tiny float, it’s no shocker it was able to make that incredible 370% move higher back in November last year. I think catalysts are coming that could help this low-float biotech garner new investor attention. As I said last night, small biotech stocks often make a move higher weeks to months before major events. And MIRA might just have one coming soon! Like in 2024 for Ketamir-2. Source: [BioPharm CATALYST]( Make sure you do your research on MIRA and everything they are working on, but I think you’ll find this useful from [their website](: What is Ketamir? A Novel Oral Ketamine Analog Ketamir-2 (“Ketamir”) is under investigation to potentially orally deliver ultra-rapid antidepressant effects for patients who have not had a meaningful response to conventional treatments, providing new hope for individuals battling treatment-resistant depression (TRD) and major depressive disorder with suicidal ideation (MDSI). And with MIRA-55 right behind it, in the first half of 2025, it’s starting to make sense to keep MIRA on your radar. Making the potential MIRA-55’s initial IND submission in the first half of 2025 an interesting drug to watch. The chart, like a lot of stocks under $10, drifts and spikes, drifts and spikes. The key is to monitor for those spikes like GME did this past month, going from $10’s to $60’s. Below, you can see the GME “drift and spike pattern.” As I said last night, MIRA is no stranger to the drift and spike pattern. Its last recent big move put up a performance that would make GME blush. Right now it’s in drift mode back down to $.66 as of Friday’s close. So the question becomes, will it spike again anytime soon? Always difficult to say but what we know about “bio runup” stocks is that they tend to start their rallies weeks to months in advance of the events. Biotech catalysts like INDs, PFUDA, phase I, II and III events can deliver some monster run-ups for stocks like MIRA. Will $.60’s be the floor ahead of the next potential GME type spike? I can’t answer that for you but it’s safe to say I think it’s worth watching here in the near-term. Spend time right now doing your own research on the stock, and of course, always approach your trading in a responsible manner. Trading is very risky, and nothing is ever guaranteed, so never trade with more than you can afford to lose. Always have a well-thought-out game plan that takes your personal risk tolerance into consideration. Bottom line: MIRA has a market-cap under $10M, a true nano-cap or the smallest of companies. Couple that with an extremely low float, and you can see how it recently went from $1.33-$6.40 in a week. Now, with it trading closer to $.60 and catalysts potentially in 2024 and early 2025, with a large addressable and fast growing market, I think there’s a good argument it may spike again soon. Don’t take your eyes off of MIRA today! 👀 To Your Success, P.S. Make sure you join me and over 1000 traders in the [Market Master’s trading room]( today for live trading signals and education. You can access it at no cost right now. *Just so you know, what you're reading is curated content for which we have received a monetary fee (detailed below) to create and distribute. Let's be clear that investing can be quite the roller coaster as stock prices can have wild swings up and down, so consider those crucial risks before you ever consider trading anything we discuss. Make sure you check out our full disclosure down below for the details on how we were paid, the risks, and why these results aren't what you'd call “typical.” Just a quick heads up about this ad you're reading—as we’ve said, even though we like the company referenced above, and all the facts we discussed above are true to the best of our knowledge, we are running a business here. To distribute this information and help offset the costs of maintaining our large digital audience, in advance of writing the content above, we received fifteen thousand dollars (cash) from Sica Media for advertising MIRA Pharmaceuticals, Inc for a one day marketing program on may 20, 2024. This amount was paid by someone else not connected to MIRA Pharmaceuticals, Inc. It might be obvious, but whoever paid for this might own shares and is likely looking to sell some or all of them at any time after we send out this information, which might affect the stock price. We may also buy or sell shares in the company at some point in the future, although neither RagingBull nor its owners own any shares of the company at this time. Also, keep in mind that due to the sheer size of our audience, if even a small percentage of people decide they want to buy this stock, it could potentially boost interest enough to hike up those share prices and cause a temporary spike, and the opposite is possible as our program ends, though that is not always the case. Now, diving right into MIRA Pharmaceuticals, Inc might sound exciting. But remember, it’s like venturing into the wilderness—be aware that there's exceptional risk involved in trading. This isn't small potatoes we're talking about; you could lose every dime you put in, so always carefully think about what you’re doing. That’s why they call this trading, after all. We're shining a light on the good stuff about the company here, but it's on you to do your homework, make your own calls, and determine a plan for your own trading, hopefully with the help of your professional 1nvestment advis0r. Oh, that brings us to another crucial point—we're not here to tell you (or even recommend) what you should do with your hard-earned money. We’re simply sharing our non-expert thoughts by highlighting some companies we like that could use some help telling their story to more people. We’re obviously biased in our writing. We’re not here to dig into anything that may be negative about the company; this is advertising, after all! Also, keep in mind that if we make some predictions about the future, these are technically known as “forward-L00king statements” under the securities acts, so take those with a grain of salt. As with all forecasts, they’re not set in stone, often wrong, and we certainly can’t know where the Company’s earnings, business, or share price will be tomorrow or a year from now. Everything you read from us is all for your education, information, and possible entertainment. While we believe the info is reliable and accurate, we can't wear a cape and guarantee it. Before you jump into anything, make sure to talk it over with a pro—someone you trust who's licensed to give you real advice. To be clear, Neither Raging Bull nor its owners, employees, or independent contractors are registered as a secur1ties br0ker-dealer, br0ker, 1nvestment advis0r (IA), or IA rep’s with the SEC, any state securities regulat0ry authority, or any self-regulat0ry organization. So, that's the scoop! If you're intrigued and want to learn more about the companies we talk about, hit up the SEC's website to dig into their filings and see the full picture. [tw]( Update your email preferences or unsubscribe [here]( © 2024 Market Navigator 62 Calef Hwy. #233 lee, NH 03861, United States of America

EDM Keywords (233)

year writing working wilderness went week website wear way watch wants want useful used us unsubscribe trust true trading traders traded tomorrow times time think thing tend tell targeting talking talk takes take stranger story store stop stocks stock starting start spikes spike soon smallest sidelines shocker shining shares shared set send sell see sec searching scoop saying say salt safe sadly running run risky risks right results research report remember reliable registered reddit received ready reading read rallied radar quite put pull price predictions possible pop point platform plan performance people patients paid owners oversold opposite one obvious notice nothing negative move months monitor mira mind might may markets market march make maintaining lot look long like light life licensed legion learn knowledge know key ketamir jump join investing investigation intrigued information info ii hope hit hike highlighting help guarantee great grain gotten giving gives give get future friday forecasts find filings fast facts eyes exactly everything everyone even email education earlier due drift dream doubt distribute discussed discuss dig determine details deliver days create course could costs content consider connected company companies community coming comes close clear check chart certainly cause case carried cape calls call buy business brings brainer big best believe back away aware audience anything answer amount america always almost afford advertising advance ad accurate access absolutely able 90 66 60 50 370 30 2035 2025 2024 10m 10

Marketing emails from marketnavigatortrading.com

View More
Sent On

12/06/2024

Sent On

11/06/2024

Sent On

11/06/2024

Sent On

10/06/2024

Sent On

10/06/2024

Sent On

09/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.